AARP Chief Executive Officer Jo Ann Jenkins released the following statement in response the Department of Labor’s proposed rule to protect Americans from conflicts of interest when financial professionals give retirement investment advice.

AARP strongly supports new bipartisan legislation, the Alleviating Barriers for Caregivers Act, which would make it easier for family caregivers to navigate key health care programs.

WASHINGTON—AARP Chief Executive Officer Jo Ann Jenkins released the following statement in response to today’s announcement of a 3.2% cost-of-living adjustment (COLA), or an average of $59...

The October issue of AARP Bulletin offers readers a slew of the latest news updates and stories – from a visual guide to fraud to the future of Medicare.

“The court’s decision to allow Medicare drug price negotiations to move forward is welcome news. Pausing Medicare negotiations would have risked billions of dollars in savings for taxpayers...

The October/November issue of AARP The Magazine (ATM) gives readers a closer look into the lives of their favorite celebrities while revealing some of the biggest trends of 2023.

AARP’s new Long-Term Services and Supports (LTSS) Scorecard finds that more than three years after the COVID-19 pandemic began, care provided in the United States for older adults and people with disabilities is painfully inadequate. The report finds that major gaps persist in every state, especially related to support for family caregivers, the long-term care workforce, equity in nursing homes, and emergency preparedness.

AARP Announces 2024 Purpose Prize® Award Winners and Fellows; Gary Sinise to Receive Honorary Purpose Prize

Actor, comedian, producer, and author Henry Winkler is more than his iconic legacy as The Fonz. In the October/November issue of AARP The Magazine (ATM), the television star opens up about his journey to escaping the beloved Happy Days character’s shadow, reclaiming his identity, and rejuvenating his career after years of typecasting.

AARP and AARP Foundation submitted an amicus brief for consideration today in the U.S. District Court for the District of Columbia, urging the court to dismiss Merck & Co.’s lawsuit challenging Medicare’s historic new authority to negotiate lower prescription drug prices.